Editorial: Cancer Care Delivery and Women’s Health: Beyond the Patient and Provider Relationship

by Sarah M. Temkin
Published 2017-09-01

Reducing overtreatment in gynecologic oncology: the case for less in endometrial and ovarian cancer

by Sarah M Temkin, Sarah M Temkin, Edward J Tanner, Summer eDewdney, Lori M Minasian
Published 2016-05-01

Black and white women in Maryland receive different treatment for cervical cancer.

by Saroj Fleming, Nicholas H Schluterman, J Katthleen Tracy, Sarah M Temkin
Published 2014-01-01

The application and outcome of standard of care treatment in elderly women with ovarian cancer: a literature review over the last 10 years.

by Steven J Gibson, Gini F Fleming, Sarah M Temkin, Dana M Chase
Published 2016-03-01

Radiation Treatment in Women with Ovarian Cancer: Past, Present, and Future

by Emma C. Fields, William P. McGuire, Lilie Lin, Sarah M. Temkin
Published 2017-08-01

Ovarian Cancer Relies on Glucose Transporter 1 to Fuel Glycolysis and Growth: Anti-Tumor Activity of BAY-876

by Yibao Ma, Wei Wang, Michael O. Idowu, Unsong Oh, Xiang-Yang Wang, Sarah M. Temkin, Xianjun Fang
Published 2018-12-01

Co-occurring substance use disorder: The impact on treatment adherence in women with locally advanced cervical cancer

by Lisa A. Rubinsak, Mishka Terplan, Caitlin E. Martin, Emma C. Fields, William P. McGuire, Sarah M. Temkin
Published 2019-05-01

Oncogenic B-Myb Is Associated With Deregulation of the DREAM-Mediated Cell Cycle Gene Expression Program in High Grade Serous Ovarian Carcinoma Clinical Tumor Samples

by Audra N. Iness, Lisa Rubinsak, Steven J. Meas, Jessica Chaoul, Sadia Sayeed, Sadia Sayeed, Raghavendra Pillappa, Sarah M. Temkin, Mikhail G. Dozmorov, Mikhail G. Dozmorov, Mikhail G. Dozmorov, Larisa Litovchick, Larisa Litovchick
Published 2021-03-01